Skip to main content
Log in

Intragastric nicotine protects against 40% ethanol-induced gastric mucosal injury despite pretreatment with propranolol orN-ethylmaleimide in rats

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

We tested the hypotheses that the protective effect of intragastric nicotine against ethanol-induced gastric mucosal injury is dependent on propranolol- orN-ethylmaleimide-sensitive mechanisms. Propranolol was administered in doses (2 and 20 mg/kg) that provided dose-related blockade of β-adrenoceptors (significant decreases in heart rate).N-Ethylmaleimide was administered in doses that previously had been shown to increase gastric vascular permeability (10 mg/kg) or inhibit gastric mucosal sulfhydryl compounds (50 mg/kg). At 0.5 hr after these or control subcutaneous pretreatments, the rats received intragastric nicotine (4 mg/kg) or vehicle. One hour later 40% ethanol was given intragastrically. The gastric corpus mucosal lesions were recorded by polaroid photographs after another hour, and their areas measured unbiasedly by computerized image analysis. The results showed thatN-ethylmaleimide, but not propranolol, aggravated ethanol-induced gastric mucosal injury. The protective effect of intragastric nicotine was not modified by either pretreatment. We conclude that the mechanism mediating intragastric nicotine protection against 40% ethanol-induced gastric mucosal injury is independent of propranolol- orN-ethylmaleimide-sensitive mechanisms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Wong SH, Ogle CW, Cho CH: The influence of chronic or acute nicotine pretreatment on ethanol-induced gastric ulceration in the rat. J Pharm Pharmacol 38:537–540, 1986

    Google Scholar 

  2. Endoh K, Baker M, Leung FW: Mechanism of intragastric nicotine protection against ethanol-induced gastric injury. Dig Dis Sci 36:39–46, 1991

    Google Scholar 

  3. Kékes-Szabó A: Pharmacological control of experimental ulcers with special regard to sympathetic activation.In Progress in Peptic Ulcer, GY Mózsik, T Jávor (eds). Budapest, Akadémiai Kiadó, 1976, pp 433–483

    Google Scholar 

  4. Fielding LP, Raute M, Curwain BP: Effect of salbutamol on acute gastric ulceration induced by indomethacin in the rat. Eur Surg Res 9:252–257, 1977

    Google Scholar 

  5. Ritchie WP Jr, Shearburn EW III: Influence of isoproterenol and cholestyramine on acute gastric mucosal ulcerogenesis. Gastroenterology 73:62–65, 1977

    Google Scholar 

  6. Moody FG, McGreevy J, Zalewsky C, Cheung LY, Simons M: The cytoprotective effect of mucosal blood flow in experimental erosive gastritis. Acta Physiol Scand (special suppl):35–43, 1978

  7. Esplugues J, Lloris JM, Marté-Bonmatí E, Morcillo EJ: Effects of β-adrenoceptor drug stimulation on various models of gastric ulcer in rats. Br J Pharmacol 76:587–594, 1982

    Google Scholar 

  8. Howard TJ, Passaro E Jr, Guth PH: Topical isoproterenol protects the rat gastric mucosa from ethanol-induced injury. J Surg Res 46:640–645, 1989

    Google Scholar 

  9. Szabo S, Trier JS, Frankel PW: Sulfhydryl compounds may mediate gastric cytoprotection. Science 214:200–202, 1981

    Google Scholar 

  10. Bálint GA, Varró V: On the cytoprotective action of sulfhydryl-containing substances. Acta Physiol Acad Sci Hung 60:139–142, 1982

    Google Scholar 

  11. Johansson C, Bergström S: Prostaglandins and protection of the gastroduodenal mucosa. Scand J Gastroenterol 17(suppl 77):21–46, 1982

    Google Scholar 

  12. Strubelt O, Hoppenkamps R: Relations between gastric glutathione and the ulcerogenic action of non-steroidal anti-inflammatory drugs. Arch Int Pharmacodyn Ther 262:268–278, 1983

    Google Scholar 

  13. Konturek SJ, Brozozowski T, Piastucki I, Radecki T, Dupuy D, Szabo S: Gastric mucosal protection by agents altering gastric mucosal sulfhydryls—role of endogenous prostaglandins. Digestion 37:65–71, 1987

    Google Scholar 

  14. Rogers C, Brown A, Szabo S: Gastric mucosal protection by new aryl sulfhydryl drugs. Dig Dis Sci 33:324–329, 1988

    Google Scholar 

  15. Hirota M, Inoue M, Ando Y, Hirayama K, Morino Y, Sakamoto K, Mori K, Akagi M: Inhibition of stress-induced gastric injury in the rat by glutathione. Gastroenterology 97:853–859, 1989

    Google Scholar 

  16. Robert A, Nezamis JE, Lancaster C, Hanchar AJ: Cytoprotection by prostaglandins in rats—prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology 77:433–443, 1979

    Google Scholar 

  17. Hoffman BB, Lefkowitz RJ: Adrenergic receptor antagonists.In Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, AG Gilman, TW Rall, AS Nies, P Taylor (eds). New York, Pergamon Press, 1990, pp 221–243

    Google Scholar 

  18. Lo SK, Leung FW, Guth PH: Protection against absolute-ethanol-induced gastric antral and corpus mucosal injury—a gross and histologic study. Dig Dis Sci 33:1403–1408, 1988

    Google Scholar 

  19. Webb JL:N-Ethylmaleimide.In Enzyme and Metabolic Inhibitors, Vol III, JL Webb (ed). New York, Academic Press, 1966, pp 337–365

    Google Scholar 

  20. Takeuchi K, Okada M, Niida H, Okabe S: Role of sulfhydryls in mucosal injury caused by ethanol—relation to microvascular permeability, gastric motility and cytoprotection. J Pharmacol Exp Ther 248:836–841, 1989

    Google Scholar 

  21. Costa M, Gabella G: Adrenergic innervation of the alimentary canal. Z Zellforsch 122:357–377, 1971

    Google Scholar 

  22. Ekue JMK, Shanks RG, Zaidi SA: Comparison of the effects of isoprenaline, orciprenaline, salbutamol and isoetharine on the cardiovascular system of anesthetized dogs. Br J Pharmacol 43:23–31, 1971

    Google Scholar 

  23. Cullum VA, Farmer JB, Jack D, Levy GP: Salbutamol—a new, selective β-adrenoceptive receptor stimulant. Br J Pharmacol 35:141–151, 1969

    Google Scholar 

  24. Hoppenkamps R, Thies E, Younes M, Siegers C-P: Glutathione and GSH-dependent enzymes in the human gastric mucosa. Klin Wochenschr 62:183–186, 1984

    Google Scholar 

  25. Boyd SC, Sasame HA, Boyd MR: High concentrations of glutathione in glandular stomach—possible implications for carcinogenesis. Science 205:1010–1012, 1979

    Google Scholar 

  26. Szabo S: Experimental basis for a role for sulfhydryls and dopamine in ulcerogenesis—a primer for cytoprotection-organoprotection. Klin Wochenschr 64(suppl VII):116–122, 1986

    Google Scholar 

  27. Miller TA, Li D, Kuo Y-J, Schmidt KL, Shanbour LL: Nonprotein sulfhydryl compounds in canine gastric mucosa—effects of PGE2 and ethanol. Am J Physiol 249(Gastrointest Liver Physiol 12):G137-G144, 1985

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by Veterans Administration Medical Research Funds, and in part by research grants (0162-01, 02 and 0291-01) from the Smokeless Tobacco Research Council, Inc., and by funds (1RT 80) provided by the Cigarette and Tobacco Surtax Fund of the State of California through the Tobacco-Related Disease Research Program of the University of California to FWL. Dr. Endoh is a recipient of the University of California Tobacco-Related Disease Research Program Research Fellowship Award (FT 37).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Endoh, K., Ro, G. & Leung, F.W. Intragastric nicotine protects against 40% ethanol-induced gastric mucosal injury despite pretreatment with propranolol orN-ethylmaleimide in rats. Digest Dis Sci 37, 391–396 (1992). https://doi.org/10.1007/BF01307733

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01307733

Key Words

Navigation